BCIFX
Price
$216.90
Change
+$1.79 (+0.83%)
Updated
Jul 3 closing price
Net Assets
43.04M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

BCIFX vs VVIAX

Header iconBCIFX vs VVIAX Comparison
Open Charts BCIFX vs VVIAXBanner chart's image
Blue Chip Investor
Price$216.90
Change+$1.79 (+0.83%)
VolumeN/A
Net Assets43.04M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
BCIFX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BCIFX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCIFX is a StrongBuy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. BCIFX (43M). VVIAX pays higher dividends than BCIFX: VVIAX (2.18) vs BCIFX (0.00). BCIFX was incepted earlier than VVIAX: BCIFX (24 years) vs VVIAX (25 years). BCIFX (1.40) is less costly to investors than VVIAX (0.05). BCIFX is a more actively managed with annual turnover of: 17.20 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than BCIFX: VVIAX (3000) vs BCIFX (5000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. BCIFX (1.02). VVIAX return over 5 years is better than : 80.13 vs. BCIFX (57.42).
BCIFXVVIAXBCIFX / VVIAX
Total Expense Ratio1.020.052,040%
Annual Report Gross Expense Ratio1.400.052,800%
Fund Existence24 years25 years-
Gain YTD4.9196.19879%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets43M189B0%
Annual Yield % from dividends0.002.18-
Returns for 1 year1.0212.038%
Returns for 3 years26.6935.1776%
Returns for 5 years57.4280.1372%
Returns for 10 years41.74115.6736%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.